Press Releases

CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.

May 24, 2018
Clinical Trial Targeting Lung Cancer, Plus Promising Osteoporosis and Incontinence Research get Support from Stem Cell Agency
May 10, 2018
California’s Stem Cell Agency Applauds FDA for Crackdown on Stem Cell Clinics that “Peddle Unapproved Treatments.”
May 7, 2018
California’s Stem Cell Agency Supports Orchard Therapeutics’ Acquisition of GSK Gene Therapy Programs for Rare Diseases
Apr 27, 2018
Therapies Targeting Cancer, Deadly Immune Disorder and Life-Threatening Blood Condition Get Almost $32 Million Boost from Stem Cell Agency
Apr 26, 2018
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
Apr 5, 2018
CIRM Launches Industry Alliance Program to Facilitate Partnerships That Advance Stem Cell Therapies
Apr 4, 2018
Stem Cell Agency-Funded Clinical Trial for Age-Related Macular Degeneration Shows Encouraging Results
Feb 22, 2018
California's Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
Jan 18, 2018
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
Jan 17, 2018
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
Dec 14, 2017
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
Nov 30, 2017
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
Oct 26, 2017
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
Oct 2, 2017
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
Sep 28, 2017
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
Sep 19, 2017
Biotech CEO David W. Martin Joins Stem Cell Agency Board
Sep 11, 2017
UCLA Launches CIRM-Funded Cancer Clinical Trial
Aug 24, 2017
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
Jul 20, 2017
Phase 3 Clinical Trial Targeting Lou Gehrig's Disease Gets $15.9 Million Investment From Stem Cell Agency
Jun 29, 2017
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
Jun 12, 2017
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board
May 25, 2017
Stem Cell Agency backs big ideas on creating a universal blood supply; regenerating injured muscles; and repairing damage caused by Alzheimer’s
May 2, 2017
CIRM Announces Leadership Transition
Apr 7, 2017
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
Mar 23, 2017
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
Mar 23, 2017
City of Hope’s Dr. Linda Malkas Appointed to Stem Cell Agency Board
Mar 17, 2017
James Harrison to Step Down as Stem Cell Agency General Counsel
Feb 23, 2017
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
Feb 8, 2017
U.C. Santa Cruz Chancellor Blumenthal Joins Stem Cell Agency Board
Jan 19, 2017
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
Dec 13, 2016
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
Dec 5, 2016
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
Nov 28, 2016
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
Nov 17, 2016
Stem Cell Agency Focuses Almost $38 Million on Colorectal Cancer, a Deadly Childhood Disorder and High Blood Pressure in the Lungs
Nov 1, 2016
Patient Advocate Leads Drive to Add Rare Diseases to CIRM’s Stem Cell Bank
Oct 24, 2016
CIRM-Funded Clinical Trial for ALS Given Go Ahead to Treat Patients
Oct 19, 2016
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
Sep 21, 2016
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
Aug 31, 2016
Stem Cell Agency Spinal Cord Injury Clinical Trial Passes Safety Hurdles
Aug 15, 2016
UC Riverside Dean Deborah Deas Joins Stem Cell Agency Board
Jul 21, 2016
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
Jun 15, 2016
CIRM Creates First of its Kind Center to Accelerate Stem Cell Development
May 19, 2016
CIRM Board Invests $7 Million in Great New Ideas and Treatment for Deadly Brain Cancer
Mar 16, 2016
CIRM Board Champions Fight Against Rare Diseases Affecting Children
Mar 6, 2016
Stem Cell Agency Honors Nancy Reagan’s Support
Feb 25, 2016
University of California, Irvine’s Dr. Howard Federoff joins CIRM Board
Feb 18, 2016
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
Jan 19, 2016
CIRM Invests $42 Million to Train Next Generation of Stem Cell Scientists
Jan 6, 2016
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
Dec 17, 2015
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future

Pages

Media Contact

Kevin McCormack
Sr. Director Public Communications & Patient Advocate Outreach
510-340-9147
kmccormack@cirm.ca.gov